Bristol Myers Squibb Named to Dow Jones Sustainability Index North America
Bristol Myers Squibb (NYSE:BMY) has been named to the 2023 Dow Jones Sustainability Index (DJSI) North America.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Bristol Myers Squibb (NYSE:BMY) has been named to the 2023 Dow Jones Sustainability Index (DJSI) North America. This recognition highlights the company's commitment to environmental, social, and governance (ESG) efforts. BMS has achieved significant progress in increasing workforce diversity, reducing its environmental footprint, and strengthening data privacy and cybersecurity measures. Additionally, BMS has incorporated ESG metrics into executive compensation to reinforce corporate governance. The DJSI North America includes the top 20% of the largest 600 North American companies in the S&P Global Broad Market Index, known for their outstanding economic, environmental, and social performance. Korab Zuka, BMS' vice president of Purpose and ESG, emphasized the company's dedication to improving sustainability practices and impacting global health positively. More details on BMS' ESG strategy can be found in their 2023 ESG Report.
Details
News Market Reaction – BMY
The recorded move for BMY in the trading session of this news was +0.05%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PRINCETON, NJ / ACCESSWIRE / June 28, 2024 / Bristol Myers Squibb Company
Recognition underscores BMS' commitment to innovation, responsibility and growth
Bristol Myers Squibb (NYSE:BMY) has been named to the prestigious 2023 Dow Jones Sustainability Index (DJSI) North America, validating the company's meaningful progress, evolved strategy and aspirational goals toward its environmental, social and governance efforts.
BMS has made significant strides toward their ESG goals, including efforts to increase workforce representation, reduce environmental impact, enhance data privacy and cyber security programs and establish principles for responsible artificial intelligence.
Additionally, the company has strengthened corporate governance by incorporating new ESG metrics into executive compensation.
The DJSI North America represents the top
"BMS is committed to driving long-term business value and continuously improving our ESG performance," said Korab Zuka, vice president, Purpose and ESG, Bristol Myers Squibb. "The recognition by the Dow Jones Sustainability Index North America honors the company's efforts to enhance our sustainability practices and positively impact the health of people, society and the planet."
BMS' ESG strategy focuses on advancing patient health and fostering a high-performing, inclusive workforce, while expanding the boundaries of science and reducing environmental impact.
Learn more about BMS' ESG strategy and commitments in its 2023 ESG Report.
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, X (formerly Twitter), YouTube, Facebook and Instagram.
Contact Info:
Spokesperson: Bristol Myers Squibb Company
Website: https://www.3blmedia.com/profiles/bristol-myers-squibb-company
Email: info@3blmedia.com
SOURCE: Bristol Myers Squibb Company
View the original press release on accesswire.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.